USPTO serial 90882531
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Megan C. Hymore
Megan C. Hymore Dinsmore & Shohl LLP255 E. Fifth streetSuite 1900Cincinnati, OH 45202| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer programs for use in conducting medical examinations and in the diagnosis and treatment of medical conditions in the field of airflow analysis and automatic segmentation of respiratory anatomy; Downloadable computer programs for information management, data collection and data analysis for medical purposes in the field of airflow analysis and automatic segmentation of respiratory anatomy; Downloadable computer programs for use by healthcare providers for reviewing, monitoring and transmission of medical images used in the primary diagnosis, treatment and care of patients in the field of airflow analysis and automatic segmentation of respiratory anatomy; Downloadable computer software using artificial intelligence for airflow analysis and automatic segmentation of respiratory anatomy; Downloadable computer software for application and database integration in the field of airflow analysis and automatic segmentation of respiratory anatomy; Downloadable computer software for controlling and managing access server applications in the field of airflow analysis and automatic segmentation of respiratory anatomy; Downloadable computer software for use as an application programming interface (API) in the field of airflow analysis and automatic segmentation of respiratory anatomy; Recorded application programming interface (API) software in the field of airflow analysis and automatic segmentation of respiratory anatomy; Recorded computer programs for use in conducting medical examinations and in the diagnosis and treatment of medical conditions in the field of airflow analysis and automatic segmentation of respiratory anatomy; Recorded computer programs for information management, data collection and data analysis for medical purposes in the field of airflow analysis and automatic segmentation of respiratory anatomy; Recorded computer programs for use by healthcare providers for reviewing, monitoring and transmission of medical images for the primary diagnosis, treatment and care of patients in the field of airflow analysis and automatic segmentation of respiratory anatomy; Recorded computer software using artificial intelligence for airflow analysis and automatic segmentation of l respiratory anatomy; all the foregoing excluding software used in orthopedic surgery | ACTIVE | — |
| 042 | Software as a service (SAAS) services featuring software using artificial intelligence for airflow analysis and automatic segmentation of respiratory anatomy; Software as a service (SAAS) services featuring software for use in database management, information management, data collection and data analysis in the field of airflow analysis and automatic segmentation of respiratory anatomy; Software as a service (SAAS) services featuring software for use in assisting medical professionals with medical examinations and in the diagnosis and treatment of medical conditions in the field of airflow analysis and automatic segmentation of respiratory anatomy; Software as a service (SAAS) services featuring software for use by healthcare providers for reviewing, monitoring and transmission of medical images for the primary diagnosis, treatment and care of patients in the field of airflow analysis and automatic segmentation of respiratory anatomy; all the foregoing excluding software services used in orthopedic surgery | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 24, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 24, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 2, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 28, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 28, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Feb 27, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Feb 27, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 18, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 18, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Oct 18, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 18, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 8, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 6, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 6, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 6, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 20, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 18, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 18, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 18, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 16, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 16, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 16, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 16, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 16, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 18, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 21, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 21, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 1, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 19, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 18, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 18, 2023 | ALIE | ASSIGNED TO LIE | — |
| Jan 18, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 18, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 18, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 1, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 30, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 30, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 20, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 20, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 20, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 4, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 17, 2021 | NWAP | NEW APPLICATION ENTERED | — |